Approximately 239 000 females developed a new ovarian cancer in 2012 and 152 000 women died globally of the disease.1 Despite its high incidence and mortality, the etiology is not fully understood; however, established epidemiological risk factors for ovarian cancer include age, parity, oral contraceptive use, tubal ligation, and inherited germline mutations in BRCA1 and BRCA2. 2, 3. This evidence concerns the gene BRCA2 and ovarian cancer.